ProQuest Investments

ProQuest Investments was founded in 1998 by healthcare executive, Jay Moorin. The company hashad over $900 million under management.

ProQuest Investments providesprovided seed to late-stage funding for healthcare companies with expertise in therapeutics, drug discovery technologies, and molecular analysis. The firm has backed over 25 companies including

ProQuest Investments was founded in 1998 by healthcare executive, Jay MoorinJay Moorin. The company has over $900 million under management.

Achillion Pharmaceuticals, ReVision Optics, Mevion Medical Systems, Rigel Pharmaceuticals, and SomaLogicSomaLogic.

Achillion PharmaceuticalsAchillion Pharmaceuticals, ReVision Optics, Mevion Medical Systems, Rigel Pharmaceuticals, and SomaLogic.

Achillion Pharmaceuticals, ReVision Optics, Mevion Medical Systems, Rigel PharmaceuticalsRigel Pharmaceuticals, and SomaLogic.

Achillion Pharmaceuticals, ReVision OpticsReVision Optics, Mevion Medical Systems, Rigel Pharmaceuticals, and SomaLogic.

ProQuest Investments was founded in 1998 by seasoned healthcare executive, Jay Moorin. The company has over $900 million under management.

ProQuest Investments provides seed to late-stage funding for healthcare companies with expertise in therapeutics, drug discovery technologies, and molecular analysis. The firm has backed over 25 companies since its inception including

ProQuest Investments was founded in 1998 by seasoned healthcare executive, Jay Moorin. The company has over $900 million under management.

ProQuest Investments provides seed to late-stage funding for healthcare companies with expertise in therapeutics, drug discovery technologies, and molecular analysis. The firm has backed over 25 companies since its inception including

Achillion Pharmaceuticals, ReVision Optics, Mevion Medical Systems, Rigel Pharmaceuticals, and SomaLogic.